625471-27-4

Basic information

• Product Name: Methyl2-Fluoro-5-iodobenzoate
• Synonyms: Methyl2-Fluoro-5-iodobenzoate;2-Fluoro-5-iodobenzoic acid methyl ester
• CAS NO: 625471-27-4
• Molecular Formula: C₈H₆FIO₂
• Molecular Weight: 280.0349132
• Mol File: 625471-27-4.mol

Chemical Properties

• Boiling Point: 293.1 °C at 760 mmHg
• Flash Point: 131.1 °C
• Appearance: /
• Density: 1.823
• Vapor Pressure: 0.00176mmHg at 25°C
• Refractive Index: 1.577
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl2-Fluoro-5-iodobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl2-Fluoro-5-iodobenzoate(625471-27-4)
• EPA Substance Registry System: Methyl2-Fluoro-5-iodobenzoate(625471-27-4)

Safety Data

• Hazardous Substances Data: 625471-27-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl2-fluoro-5-iodobenzoate is used as an intermediate in the synthesis of various pharmaceuticals for its unique reactivity and properties. Its presence of fluoro and iodine substituents allows for the development of new drug molecules with improved therapeutic effects.
Used in Agrochemical Industry:
Methyl2-fluoro-5-iodobenzoate is used as an intermediate in the synthesis of agrochemicals, contributing to the development of new pesticides and other agricultural chemicals with enhanced efficacy and selectivity.
Used in Organic Synthesis:
Methyl2-fluoro-5-iodobenzoate is used as a reagent in organic synthesis, including in cross-coupling reactions. Its unique reactivity allows for the formation of new organic compounds with potential applications in various industries.
Used as a Building Block:
Methyl2-fluoro-5-iodobenzoate serves as a building block in the production of various organic compounds, enabling the creation of a wide range of molecules with diverse applications.
It is important to handle Methyl2-fluoro-5-iodobenzoate with care, as it may have hazardous properties. Proper safety measures should be taken during its use in research and industrial applications.

InChI:InChI=1/C8H6FIO2/c1-12-8(11)6-4-5(10)2-3-7(6)9/h2-4H,1H3

Upstream product

• 67-56-1 methanol 
• 124700-41-0 2-fluoro-5-iodobenzoic acid 
• 2965-22-2 methyl 2-fluoro-5-nitro-benzoate 
• 7304-32-7 2-fluoro-5-nitrobenzoic acid 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 
• 56741-34-5 methyl 5-amino-2-fluorobenzoate 

Downstream Products

• 272130-83-3 methyl 2-fluoro-5-vinylbenzoate 
• 1129401-69-9 methyl 2-fluoro-5-(4-nitrobenzoyl)benzoate 
• 782493-44-1 tert-Butyl 4-[4-fluoro-3-(methoxycarbonyl)phenyl]piperidine-1-carboxylate 
• 881493-38-5 methyl 2-fluoro-5-(piperidin-4-yl)benzoate hydrochloride 
• 782493-48-5 tert-butyl 4-(3-{[(4-methylphenyl)sulfonyl]oxy}-1,2-benzisoxazol-5-yl)piperidine-1-carboxylate 
• 782493-46-3 5-piperidin-4-yl-1,2-benzisoxazol-3-yl 4-methylbenzenesulfonate hydrochloride 
• 1129401-67-7 5-(4-bromobenzoyl)-2-fluorobenzoic acid methyl ester 
• 874219-35-9 (4-fluoro-3-(methoxycarbonyl)phenyl)boronic acid 
• 165803-94-1 methyl 2-fluoro-5-formylbenzoate 
• 1226985-35-8 C₈H₇IN₂O 
• 782493-45-2 tert-butyl 4-[4-fluoro-3-(methoxycarbonyl)phenyl]-3,6-dihydropyridine-1(2H)-carboxylate 
• 1276035-85-8 C₂₂H₁₅F₄N₃O₂ 
• 1276040-22-2 C₂₂H₁₈F₄N₂O₃ 
• 1276039-98-5 C₁₅H₁₂F₃NO₃ 

Relevant articles and documents

Palladium-Catalyzed β-Arylation of Amide via Primary sp3C-H Activation

A β-arylation of primary sp3C-H bonds on simple amides such as pivalamides with aryl iodides/CF3CO2Ag has been established successfully at 120 °C in a Pd(OAc)2 (catalyst)/CF3CH2OH (solvent) system. Pivalamides including tBuCONH2, tBuCONHR, and tBuCONR2 undergo the arylations smoothly to afford β-aryl pivalamides in moderate to good yields. Various aryl iodides are available bearing either electron-donating or electron-withdrawing substituted groups in the coupling reactions.

QUINAZOLINONE DERIVATIVES AS VIRAL POLYMERASE INHIBITORS

Compounds of formula I: (I) wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION

There is provided compounds of formula (I): wherein Y, ring A, D1, D2, D3, L1, Y1, L2, Y2, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.

BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS

There is provided compounds of formula (I), wherein E1, E2a, E2b, E2c, E4, D1, D2, D3, L1, Y1, L2 and Y2 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.

VIRAL POLYMERASE INHIBITORS

Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

VIRAL POLYMERASE INHIBITORS

Compounds of formula I: wherein X, R2, R3, R3a, R3b,R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS

Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula I: which are used to modulate the CCR-2 chemokine receptor to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions.

BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS

Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula (I): which are used to modulate the CCR-